Skip to: Curated Story Group 1
Visually Open Nav.
Advertise
with us
US
EUROPE
APAC
CANADA
LATAM
subscribe
Open Search Field.
Home
Topics
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Business Services
Business Services
Business Services
Business Services
Business Services
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Pharmacy Management
Regulatory Services
Technologies and Software
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
Whitepapers
Magazine
CXO Awards
MARCH - APRIL 2026 6LIFE SCIENCES REVIEWIn laboratory-driven industries, continuity is not optional. As regulatory scrutiny intensifies and supply chains remain complex across Latin America, distributors are being measured not by product breadth alone, but by their ability to deliver reliability at scale.Our cover story recognizes El Crisol S.A. de C.V. as the Top Laboratory Equipment and Materials Distributor in Latin America 2026. As detailed in this issue, the company has built its leadership on a disciplined inventory-first strategy, institutional governance and deep operational foresight. While much of the global distribution sector has leaned toward just-in-time models, El Crisol has consistently invested in inventory depth across 15 warehouses in Mexico and a U.S. hub, ensuring more than 95 percent catalog availability. Its three-tier portfolio, private-label development under Lauka and Roca, SAP-integrated procurement systems and bidirectional PunchOut catalogs reflect a distributor structured around application precision and supply continuity. In volatile markets, this approach has positioned El Crisol as an operational safeguard for laboratories serving life sciences, research, public health and industrial production.This edition also recognizes Luminova Pharma Group as the Top Pharmaceutical Microgranule Form Products Manufacturer in Latin America 2026. The company's expertise in multiparticulate microgranule formulations supports controlled drug release, improving therapeutic consistency and patient tolerability compared with conventional immediate-release dosage forms.The CXO perspectives in this edition reinforce the operational rigor required on the customer side. Mackey Martarona, Director of Laboratory Service at St. Tammany Health System, underscores the importance of automation, data transparency and continuous compliance cycles in sustaining laboratory performance. Stephanie Whitehead, Executive Director of Pathology Services at University Health, provides a structured framework for evaluating new laboratory equipment, emphasizing utility, staffing impact, clinical need, long-term capability and total cost considerations. Reliability is not a slogan in this sector but the infrastructure. We invite you to examine how leadership, operational discipline and forward planning are redefining what it means to distribute, procure and deploy laboratory systems across Latin America.EDITORIALDefining Excellence in Laboratory Equipment DistributionCopyright © 2026 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com MARCH - APRIL 2026, Vol 07, Issue - 06 (ISSN 2831-8331) ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersPresley MeadowDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsHenry SmithClara MatthewLATAM
<
Page 5
|
Page 7
>